Latest Safety News

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Norfolk Metals reports progress in its Orroroo Uranium and Roger River projects, unveiling new exploration targets and maintaining a solid financial footing with $2.66 million in cash.

Geopacific Resources has successfully raised $40 million through a renounceable entitlement offer to advance its 1.67 million ounce Woodlark Gold Project, with a major drilling campaign and updated feasibility study planned for 2025.

Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.

Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.

Invion Limited has marked significant progress in its cancer treatment pipeline, dosing the first patient in a pivotal skin cancer trial and reporting encouraging prostate cancer results, while securing fresh funding to support ongoing development.

Gibb River Diamonds secures key agreements to progress gold mining at Edjudina and gains international exposure for its Ellendale Diamond Project, positioning itself for growth across multiple mineral fronts.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Linius Technologies has appointed Ben Taverner as CEO and secured key partnerships and customers, including Brown University and Fujitsu, setting the stage for significant growth in FY25.

EQ Resources Limited reported a record quarterly tungsten concentrate production of 33,249 mtu, driven by operational excellence at its Saloro mine and strategic acquisitions including Tungsten Metals Group Ltd. Despite challenges at Mt Carbine due to low rainfall, the company secured significant funding and is poised for growth.

Arika Resources has expanded its exploration footprint at the Yundamindra Gold Project with over 25 new high-priority gold targets identified and a $3.2 million capital raise to fast-track drilling programs. The company awaits assay results from recent drilling that could redefine the project's scale.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for Autosomal Dominant Optic Atrophy, marking a pivotal step in developing a treatment for this currently untreatable blinding disease.